Boston Scientific Corporation Announces Offer to Acquire
Guidant Corporation at $80 per Share
Boston Scientific Corporation announced a compelling offer of $80
per share, or approximately $27 billion in the aggregate, to acquire
Guidant Corporation. This offer is set forth in a merger agreement
that was executed by Boston Scientific and delivered to Guidant
today.
Under the terms of the amended offer, Boston Scientific will
acquire all of the outstanding shares of Guidant for $80 per share,
$42.00 in cash and $38.00 in Boston Scientific common stock, subject
to a collar.
Boston Scientific's offer price represents a premium of $3.3
billion (or $9 per share) over the purchase price proposed to be
paid by Johnson & Johnson, based on the closing price of Johnson &
Johnson common stock on Friday, January 13, 2006. Guidant
shareholders will own approximately 36 percent in the combined
company with significant upside potential and value.
New MRI Technology Shows More Realistic 3-D Views of Organs
Researchers from the University of Tokyo and Shiga University of
Medical Science have teamed with GE Yokogawa Medical Systems Ltd. to
develop a way to present doctors with more realistic 3-D views of
organs during surgery based on cross-sectional pictures taken with
MRI (magnetic resonance imaging).
It remains technically challenging to convert MRI images
immediately into 3-D views of organs, but the new procedure
compensates by preparing a series of 3-D images that take into
account the movements that occur due to breathing and heart action.
The goal is to have a practical version of the technology ready
after three years. In the procedure, a series of cross-sectional MRI
images are captured and divided into sets based on the breathing
pattern and heart rate, and each set is used to generate a 3-D image
of the organ in question.
Nothing else this week of much note.
If you have any comments, please email them to
info@mdiconsultants.com
<< Previous Page
>>
